600
Participants
Start Date
September 15, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
July 30, 2026
PG-011 nasal spray 0.6%(twice daily)
2 sprays in each nostril, twice daily for 14-day treatment period.
Placebo
2 sprays in each nostril, twice daily for 14-day treatment period.
Beijing Shijitan Hospital, Capital Medical University, Beijing
Beijing Tongren Hospital, Capital Medical University, Beijing
Beijing Youan Hospital, Capital Medical University, Beijing
Peking University Third Hospital, Beijing
Gansu Provincial people's Hospital, Lanzhou
The NO. 2 Hospital of Baoding, Baoding
Cangzhou Central Hospital, Cangzhou
Hebei Petro China Central Hospital, Langfang
Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang
Hebei Provincial People's Hospital, Shijiazhuang
Daqing people's Hospital, Daqing
Harbin Medical University Affiliated Fourth Hospital, Harbin
Luo Yang First People's Hospital, Luoyang
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
Zhengzhou Central Hospital, ,, Zhengzhou
The Central Hospital of Wuhan, Wuhan
Tonghua Central Hospital, Tonghua
The central hospital of shenyang medical college, Shengyang
Shengjing Hospital of China Medical University, Shenyang
Baotou Central Hospital, Baotou
Chifeng Municipal Hospital, Chifeng
Affiliated Hospital Of Inner Mongolia Medical University, Hohhot
First People's Hospital of Yinchuan, Yinchuan
People's Hospital of Ningxia Hui autonomous region, Yinchuan
Shandong Second Provincial People's Hospital, Jinan
Liaocheng People's Hospital, Liaocheng
Yantai YuHuangDing Hospital, Yantai
Zibo Central Hospital, Zibo
Sinopharm Tongmei General Hospital, Datong
Linfen Central Hospital, Linfen
Linfen People's Hospital, Linfen
First Hospital of Shanxi Medical University, Taiyuan
Shanxi Bethune Hospital, Taiyuan
The Second Hospital of Shanxi Medical University, Taiyuan
Xianyang Hospital of Yan'an University, Xianyang
The First Affiliated Hospital of Xi'an Jiao Tong University, Xi’an
Xian XD Group Hospital, Xi’an
Yuncheng Central Hospital, Yuncheng
Lead Sponsor
Prime Gene Therapeutics Co., Ltd.
INDUSTRY